Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 113Colonic Neoplasms 30Neoplasm Metastasis 28Rectal Neoplasms 27Neoplasms 27Carcinoma, Non-Small-Cell Lung 14Esophageal Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Head and Neck Neoplasms 9Lung Neoplasms 8Cholangiocarcinoma 7Carcinoma, Squamous Cell 6Breast Neoplasms 6Colorectal Cancer Metastatic 5Carcinoma 5Triple Negative Breast Neoplasms 4Recurrence 4Prostatic Neoplasms 4Ovarian Neoplasms 4Inflammatory Breast Neoplasms 3Gastrointestinal Neoplasms 3Adenocarcinoma Of Esophagus 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Kidney Neoplasms 2Glioma 2Fallopian Tube Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 17Iodine-131 16lenvatinib 13trametinib 12Thyrotropin Alfa 11Sorafenib 11pembrolizumab 10dabrafenib 10Paclitaxel 9vandetanib 8Thyroxine 8Surgical Procedures, Operative 7Sunitinib 7selpercatinib 6cabozantinib 6Nivolumab 6Fluorodeoxyglucose F18 6Everolimus 6pazopanib 5Vemurafenib 5Thyroidectomy 5Specimen Handling 5Saline Solution 5Radiotherapy 5Radiofrequency Ablation 5Cyclophosphamide 5Cisplatin 5Biopsy 5apatinib 4anlotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thyroid Neoplasms × Panitumumab × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡